top of page

Catalyst Pharma CEO Richard Daly gives an overview of the company's three commercial products, and discusses the 'buy to build' model

  • Sep 8, 2025
  • 1 min read

Updated: Sep 9, 2025

He highlights the market penetration of FIRDAPSE, the differentiation he believes AGAMREE represents in the DMD space, and FYCOMPA. Plus, the company's financial strength.




Coverage brought to you by:


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page